Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Nutraceutical/Dietary Intervention for Neurofibromatosis, type 1
Largaespada, D. A. & Moertel, C. L.
3/1/21 → 1/1/24
Project: Research project
-
Efficacy and Safety of Trametinib Monotherapy or in Combination with Dabrafenib in Pediatric BRAF V600-Mutant Low-Grade Glioma
Bouffet, E., Geoerger, B., Moertel, C., Whitlock, J. A., Aerts, I., Hargrave, D., Osterloh, L., Tan, E., Choi, J., Russo, M. & Fox, E., Jan 20 2023, In: Journal of Clinical Oncology. 41, 3, p. 664-674 11 p.Research output: Contribution to journal › Article › peer-review
6 Scopus citations -
Sex differences in methylation profiles are apparent in medulloblastoma, particularly among SHH tumors
Moss, R. M., Sorajja, N., Mills, L. J., Moertel, C. L., Hoang, T. T., Spector, L. G., Largaespada, D. A. & Williams, L. A., 2023, In: Frontiers in Oncology. 13, 1113121.Research output: Contribution to journal › Article › peer-review
Open Access -
CD200AR-L: mechanism of action and preclinical and clinical insights for treating high-grade brain tumors
Moertel, C., Martinez-Puerta, F., Pluhar, G. G. E., Castro, M. G. & Olin, M., 2022, In: Expert Opinion on Investigational Drugs. 31, 9, p. 875-879 5 p.Research output: Contribution to journal › Editorial › peer-review
1 Scopus citations -
Maternal Contraceptive Use and Central Nervous System Tumors in Offspring
Spector, L. G., Moertel, C. L. & Su, H. I., Jan 4 2022, In: JAMA - Journal of the American Medical Association. 327, 1, p. 39-40 2 p.Research output: Contribution to journal › Editorial › peer-review
-
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus
De Blank, P. M. K., Gross, A. M., Akshintala, S., Blakeley, J. O., Bollag, G., Cannon, A., Dombi, E., Fangusaro, J., Gelb, B. D., Hargrave, D., Kim, A. R., Klesse, L. J., Loh, M., Martin, S., Moertel, C., Packer, R., Payne, J. M., Rauen, K. A., Rios, J. J., Robison, N., & 12 others, Nov 1 2022, In: Neuro-Oncology. 24, 11, p. 1845-1856 12 p.Research output: Contribution to journal › Review article › peer-review
Open Access5 Scopus citations